trending Market Intelligence /marketintelligence/en/news-insights/trending/mv62FXCK08P4iITuIcBy6A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Aflac resembles P&C insurer, says Macquarie

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

Aflac resembles P&C insurer, says Macquarie

Macquarie analyst Sean Dargan on April 14 raised hisinvestment opinion on AflacInc. to "outperform" from "neutral," and raisedhis price target to $76 from $63.

"With solid underwriting margins in Japan, we believeAflac does not need sales growth at any costs nor does it need help frominterest rates to generate superior unlevered returns on capital forshareholders," he wrote. In that regard, the company more closelyresembles a P&C insurer.

The growing demand of third sector insurance products, whichcomprise cancer, medical and long-term care insurance, in Japan as well asAflac's position as a market leader in that line of business there, presents agreat growth opportunity for the insurer, according to Dargan.

Dargan raised his 2016 EPS estimate to $6.55 from $6.35,2017 EPS estimate to $6.90 from $6.75 and 2018 EPS estimate to $7.30 from $7.05.